Company profile
Bicycle Therapeutics company profile
Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
Business identity
- Contact email
- [email protected]
- Phone number
- +44 1223 497 415
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 251-500 employees
- Revenue range
- $1M-$10M
- Founded
- 2009-01-01, Year
Headquarters
- Headquarters
- Cambridge, England, United Kingdom
- Postal code
- CB22 3AT
- Country code
- GB
- Continent
- Europe